List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 3828 studies with search of: updated in the last 14 days
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Intervention: Drug: epothilone b
2 Completed Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: anakinra;   Drug: pegsunercept
3 Active, not recruiting Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients
Condition: Parkinson Disease
Interventions: Drug: pramipexole IR;   Drug: ropinirole
4 Recruiting Pompe Disease Registry
Conditions: Glycogen Storage Disease Type II;   Pompe Disease
Intervention:
5 Completed Randomized Clinical Trial of Vitamin E and Evening Oil of Primrose for the Managment of Breast Pain
Condition: Cyclical Breast Pain
Intervention: Drug: Vitamin E, Evening Oil of Primrose, and Placebo
6 Recruiting Lipid Efficacy and Safety in Patients With Mixed Hyperlipidemia
Condition: Mixed Hyperlipemia
Interventions: Drug: MK0524B;   Drug: Atorvastatin
7 Active, not recruiting Phase 1b Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Breast Cancer
Condition: Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Paclitaxel;   Drug: AMG 706
8 Active, not recruiting Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: pemetrexed;   Drug: cisplatin;   Procedure: Radiation Therapy
9 Recruiting MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: dexamethasone;   Drug: Fludarabine;   Drug: Melphalan
10 Suspended A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma
Condition: Melanoma
Intervention: Drug: CP-675,206
11 Recruiting Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Condition: Colorectal Cancer
Interventions: Drug: cediranib maleate;   Drug: irinotecan hydrochloride
12 Recruiting Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: letrozole;   Drug: tamoxifen citrate;   Other: placebo
13 Recruiting Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD)
Condition: Hemodialysis Patients
Interventions: Device: large pore (FX80) compared to small pore dialyzer (F8HPS);   Other: Dialysate bicarbonate of 33 mEq/L compared to 40 mEq/L;   Other: Dialysate calcium of 3 mEq/L compared to 2.5 mEq/L
14 Recruiting ADO II Clinical Study
Condition: Patent Ductus Arteriosus
Intervention: Device: AMPLATZER Duct Occluder II
15 Withdrawn Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma
Condition: Colorectal Carcinoma
Interventions: Other: Cetuximab and Radiation Therapy;   Procedure: Surgery and Radiation Therapy
16 Recruiting Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis
Condition: Cysic Fibrosis
Interventions: Drug: tiotropium respimat;   Drug: placebo
17 Recruiting Dose Range Finding Study of MK0941 in Patients With Type 2 Diabetes on Insulin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Comparator: MK0941;   Drug: Comparator: Placebo;   Biological: Comparator: Lantus
18 Recruiting (ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: ambrisentan or sugar pill
19 Recruiting Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions: Brain and Central Nervous System Tumors;   Chemotherapeutic Agent Toxicity;   Cognitive/Functional Effects;   Neurotoxicity;   Psychosocial Effects of Cancer and Its Treatment;   Radiation Toxicity;   Therapy-related Toxicity
Interventions: Other: questionnaire administration;   Procedure: cognitive assessment;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
20 Recruiting Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Procedure: observation;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services